NASDAQ:GP

Pfizer stock dips as U.S. vaccine policy fight rattles demand outlook

Pfizer shares fell 0.6% to $25.42 in late-morning trading Thursday as U.S. vaccine policy changes fueled uncertainty. Sanofi warned of weaker U.S. vaccine demand; Pfizer’s CEO criticized the new recommendations. Moderna and Merck also traded lower. Investors await Pfizer’s Feb. 3 results for updates on 2026 outlook and new product pipeline.

15 January 2026

NASDAQ:GP·NASDAQ:MRNA·NYSE:LLY·NYSE:MRK·NYSE:NVO·NYSE:PFE·NYSE:SNY·Pharmaceuticals·Stock Market

Biggest Stock Gainers Today in the US (Dec. 9, 2025): Wave Life Sciences, Structure Therapeutics, Confluent and More

Wave Life Sciences shares jumped about 147% Monday after positive data on its experimental RNA obesity drug, leading US stock gainers. The Dow fell 0.45%, S&P 500 lost 0.35%, and Nasdaq slipped 0.14% as investors awaited Wednesday’s Federal Reserve decision. Nvidia rose after the US allowed exports of its H200 AI chips to China with a 25% fee.

9 December 2025

NASDAQ:CFLT·NASDAQ:GP·NASDAQ:WVE·Stock Market·US Stocks